Janaszkiewicz Angelika, Tóth Ágota, Faucher Quentin, Arnion Hélène, Védrenne Nicolas, Barin-Le Guellec Chantal, Marquet Pierre, Di Meo Florent
Inserm U1248 Pharmacology & Transplantation, Univ. Limoges, 87000 Limoges, France.
Inserm U1248 Pharmacology & Transplantation, Univ. Limoges, 87000 Limoges, France; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utre-cht University, 3584 CG Utrecht, The Netherlands.
Biomed Pharmacother. 2023 Apr;160:114342. doi: 10.1016/j.biopha.2023.114342. Epub 2023 Feb 3.
The Organic Anion Transporter 1 is a membrane transporter known for its central role in drug elimination by the kidney. hOAT1 is an antiporter translocating substrate in exchange for a-ketoglutarate. The understanding of hOAT1 structure and function remains limited due to the absence of resolved structure of hOAT1. Benefiting from conserved structural and functional patterns shared with other Major Facilitator Superfamily transporters, the present study intended to investigate fragments of hOAT1 transport function and modulation of its activity in order to make a step forward the understanding of its transport cycle. μs-long molecular dynamics simulation of hOAT1 were carried out suggesting two plausible binding sites for a typical substrate, adefovir, in line with experimental observations. The well-known B-like motif binding site was observed in line with previous studies. However, we here propose a new inner binding cavity which is expected to be involved in substrate translocation event. Binding modes of hOAT1 co-substrate α-ketoglutarate were also investigated suggesting that it may bind to highly conserved intracellular motifs. We here hypothesise that α-ketoglutarate may disrupt the pseudo-symmetrical intracellular charge-relay system which in turn may participate to the destabilisation of OF conformation. Investigations regarding allosteric communications along hOAT1 also suggest that substrate binding event might modulate the dynamics of intracellular charge relay system, assisted by surrounding lipids as active partners. We here proposed a structural rationalisation of transport impairments observed for two single nucleotide polymorphisms, p.Arg50His and p.Arg454Gln suggesting that the present model may be used to transport dysfunctions arising from hOAT1 mutations.
有机阴离子转运体1是一种膜转运蛋白,因其在肾脏药物消除中的核心作用而闻名。人有机阴离子转运体1(hOAT1)是一种反向转运体,它转运底物以交换α-酮戊二酸。由于缺乏hOAT1的解析结构,对其结构和功能的理解仍然有限。受益于与其他主要易化子超家族转运蛋白共有的保守结构和功能模式,本研究旨在研究hOAT1转运功能的片段及其活性调节,以便在理解其转运循环方面取得进展。对hOAT1进行了微秒级的分子动力学模拟,结果表明一种典型底物阿德福韦有两个可能的结合位点,这与实验观察结果一致。与先前的研究一致,观察到了著名的B样基序结合位点。然而,我们在此提出了一个新的内部结合腔,预计它参与底物转运事件。还研究了hOAT1共底物α-酮戊二酸的结合模式,表明它可能与高度保守的细胞内基序结合。我们在此假设,α-酮戊二酸可能破坏假对称的细胞内电荷中继系统,这反过来可能参与OF构象的不稳定。对hOAT1上的变构通讯的研究还表明,底物结合事件可能会调节细胞内电荷中继系统的动力学,周围脂质作为活性伙伴起到辅助作用。我们在此提出了对两种单核苷酸多态性p.Arg50His和p.Arg454Gln所观察到的转运损伤的结构合理化解释,表明当前模型可用于解释由hOAT1突变引起的转运功能障碍。